27 December 2002 :
Co-targeting HER2/ErbB2 and insulin-like growth factor-1 receptors causes synergistic inhibition of growth in HER2-overexpressing breast cancer cells.
Med Sci Monit 2002; 8(12): BR521-526 :: ID: 4817
HTML version available soon